Not medical advice. This article is based on published clinical trial data and commonly reported patient experiences. It is not a substitute for advice from your own GP, diabetes nurse, or prescribing clinician. If you have any concerns about your blood glucose readings, contact your healthcare team promptly.
How tirzepatide affects blood glucose
Mounjaro works through two complementary mechanisms that lower blood sugar. It mimics two gut hormones — GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) — that are released naturally after eating.
These hormones do three things that directly lower blood glucose:
- Stimulate insulin release — but only when glucose is high. This is glucose-dependent, meaning the risk of hypoglycaemia is lower than with insulin or sulphonylureas.
- Suppress glucagon — glucagon is the hormone that tells your liver to release stored glucose. Blocking it reduces the liver's glucose output, which is a major driver of high fasting readings.
- Slow gastric emptying — food moves through the stomach more slowly, so post-meal glucose spikes are flatter and more gradual.
The result is a sustained, progressive reduction in both fasting and post-meal glucose — but this effect builds up over weeks, not days.
Week-by-week glucose pattern on Mounjaro
Most people with type 2 diabetes experience a consistent pattern in the first 8 weeks. The timeline below reflects typical findings from SURPASS clinical trial data and commonly reported patient experiences.
Little change — the adjustment phase
At 2.5 mg, the glucose-lowering effect is modest. Most people see minimal change in fasting readings. You may notice reduced appetite and some nausea — these are the early signs the drug is working. Don't be discouraged by flat glucose numbers this early.
Significant glucose drop — highest risk period
This is when most people see their biggest glucose reductions. Fasting readings that were at 9–12 mmol/L may drop to 6–8 mmol/L within a few weeks. Post-meal spikes flatten considerably. If you are on sulphonylureas (like gliclazide) or insulin, this is the period when your GP may need to reduce those doses to prevent hypoglycaemia.
Dose increase to 5 mg — renewed drop
After 4 weeks at 2.5 mg you escalate to 5 mg. Expect a further glucose reduction — often another 1–2 mmol/L off fasting readings. Nausea may return briefly at each dose increase. Glucose stabilises again by the end of weeks 11–12.
Progressive improvement with each escalation
Each dose increase produces a further step-down in glucose. The pattern continues: escalate, brief adjustment, new stable lower baseline. Most people reach their best glucose control at their optimal dose — which for many is 7.5 mg or 10 mg, not necessarily 15 mg.
Target blood glucose ranges on Mounjaro
The ranges below are the standard NHS guidance for type 2 diabetes. Discuss your personal targets with your GP, as they may differ based on your history.
The dawn phenomenon on Mounjaro — why morning readings can be higher
A common source of confusion for Mounjaro patients is the "dawn phenomenon": fasting readings in the morning can be noticeably higher than bedtime readings from the night before, even after weeks of improving trends.
This happens because of natural cortisol and growth hormone surges in the early morning hours (roughly 3–8 am). These hormones tell the liver to release glucose in preparation for waking up. In people with type 2 diabetes, the insulin response to this liver glucose dump is impaired.
Mounjaro suppresses glucagon (which drives daytime post-meal spikes) but the dawn phenomenon is primarily hormone-driven — making it harder to control with GLP-1 and GIP agonists than post-meal spikes.
What the dawn phenomenon looks like on Mounjaro
- Bedtime reading: 6.2 mmol/L (normal)
- Morning fasting reading: 8.1 mmol/L (apparently worse)
- Post-breakfast reading: 7.4 mmol/L (better than expected given fasting)
This pattern — bedtime good, morning high, then dropping again — is the dawn phenomenon, not a sign that Mounjaro has stopped working.
If your morning readings remain consistently above 9 mmol/L despite several weeks at a given dose, mention it to your prescriber. Adjusting injection timing (evening vs morning) can help — ask your prescriber whether this is appropriate for you.
When to contact your GP
Mounjaro is generally safe, but because it can lower glucose significantly — especially in combination with other diabetes medications — there are specific thresholds that warrant prompt GP contact.
Contact your GP if:
- Any reading below 4.0 mmol/L — this is the clinical hypoglycaemia threshold. Treat immediately with fast-acting glucose (glucose tablets, regular sugary drink) then contact your GP to discuss whether your other diabetes medications need reducing.
- Repeated fasting readings below 5.0 mmol/L — your existing diabetes medications (especially sulphonylureas or insulin) may need dose reduction.
- Persistent nausea or vomiting preventing food intake — this can cause glucose to drop unpredictably. Seek guidance if it lasts more than 48 hours.
- Fasting readings consistently above 12 mmol/L after 8 weeks — may indicate that dose escalation or a medication review is needed.
- Any hypoglycaemic symptoms — shaking, sweating, confusion, palpitations — regardless of what your meter reads.
Common questions about Mounjaro and blood glucose
Can Mounjaro cause low blood sugar (hypoglycaemia)?
On its own, Mounjaro has a low hypoglycaemia risk because its insulin-stimulating effect is glucose-dependent — it doesn't release insulin when your glucose is already normal or low. However, when combined with sulphonylureas (gliclazide, glipizide) or insulin, the combined effect can push glucose below safe levels. Always tell your prescriber what other diabetes medications you are on.
Why are my post-meal readings better than my morning readings?
This is normal and usually reflects the dawn phenomenon described above. Mounjaro is particularly effective at blunting post-meal spikes. If your fasting readings are frustratingly persistent while post-meal readings improve, this is a common pattern — especially in the first 12 weeks.
How quickly should I expect my HbA1c to improve?
HbA1c reflects average glucose over the past 2–3 months, so improvements in daily readings won't show up in your HbA1c immediately. Most people see a meaningful drop in their HbA1c test 12–16 weeks after starting Mounjaro, with the biggest improvements typically at the 6-month mark. In the SURPASS-2 trial, participants reduced HbA1c by an average of 2.0–2.5 percentage points over 40 weeks.
The importance of tracking your readings
Tracking your glucose daily is not just reassuring — it has direct practical benefits when you are on Mounjaro:
- It helps you and your GP identify whether your current dose is working or whether escalation is needed
- It provides evidence for whether other diabetes medications can be safely reduced
- It helps distinguish the dawn phenomenon from genuine poor control
- It builds the 90-day record your GP needs to make informed prescribing decisions
The QumranHealth glucose tracker is free to use and automatically calculates estimated HbA1c, flags readings in the caution zone, and generates a clean GP-ready report. It takes 30 seconds a day.
Track your glucose on Mounjaro — free
Log fasting and post-meal readings daily. See your 8-week trend at a glance. Get a GP-ready 90-day report — including HbA1c estimate and hypo flag — to share with your clinician.
Start Free — tracker.qumranhealth.co.ukFinal reminder — not medical advice. The information in this article is based on published clinical data and common patient experiences on Mounjaro. Your individual response may differ. Always discuss your glucose readings, medication adjustments, and any symptoms with your GP, diabetes nurse, or prescribing clinician. Do not adjust your other diabetes medications without professional guidance.